current
studi
design
assess
inhibitori
activ
broussonetia
papyriferaderiv
polyphenol
papainlik
coronaviru
cystein
proteas
isol
compound
broussochalcon
b
broussochalcon
papyriflavonol
kazinol
kazinol
b
broussoflavan
kazinol
f
kazinol
j
polyphenol
potent
papainlik
proteas
pl
pro
proteas
pro
therefor
investig
structur
featur
respons
select
compound
potent
inhibitor
pl
pro
ic
valu
lm
activ
compound
display
kinet
behavior
bind
constant
interact
pl
pro
determin
surfac
plasmon
reson
analysi
result
suggest
b
papyrifera
constitu
promis
candid
develop
potenti
anticoronavir
agent
articl
histori
sever
acut
respiratori
syndrom
sar
contagi
often
fatal
respiratori
ill
first
report
guangdong
provinc
china
novemb
diseas
quickli
spread
asian
countri
north
america
europ
infect
individu
caus
approxim
death
recent
sar
began
fade
public
memori
new
coronaviru
call
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
pathogen
human
cov
merscov
sarscov
kill
approxim
infect
patient
saudi
arabia
south
korea
alarm
new
deadli
cov
emerg
time
potenti
becom
pandem
unfortun
neither
protect
vaccin
effect
antivir
agent
prevent
treatment
sar
avail
therefor
continu
develop
therapeut
prophylact
countermeasur
potenti
deadli
cov
warrant
sarscov
crownlik
envelop
viru
contain
positivestrand
rna
whose
genom
sequenc
exhibit
moder
homolog
known
cov
sinc
sarscov
proteas
proteas
pro
papainlik
proteas
pl
pro
synthes
larg
precursor
protein
cleav
gener
matur
activ
protein
structur
conserv
across
cov
genera
target
protein
effect
antivir
strategi
suppress
viral
genom
replic
cure
cov
infect
continu
interest
natur
productderiv
anticov
candid
report
studi
inhibitori
action
polyphenol
broussonetia
papyrifera
cov
proteas
previous
report
aglucosidas
inhibitori
activ
polyphenol
genu
depend
number
prenyl
group
molecul
mani
natur
inhibitor
variou
glucosidas
explor
potenti
applic
medicin
carbohydratemedi
diseas
cancer
diabet
infecti
diseas
endoplasm
reticulum
aglucosidas
respons
stepwis
remov
termin
glucos
residu
nglycan
chain
attach
nascent
glycoprotein
reaction
first
step
nlink
glycan
process
essenti
proper
fold
function
mani
glycoprotein
viral
envelop
glycoprotein
contain
nlink
glycan
aglucosidas
inhibitor
castanospermin
propos
potenti
use
broadspectrum
antivir
agent
base
activ
varieti
envelop
virus
encourag
preliminari
find
focus
attent
investig
antivir
activ
polyphenol
cov
cystein
proteas
character
evalu
antisarsm
activ
follow
b
papyrifera
rootderiv
glucosidas
inhibitor
broussochalcon
b
broussochalcon
papyriflavonol
kazinol
kazinol
b
broussoflavan
kazinol
f
kazinol
j
preliminari
biochem
screen
natur
deriv
compound
compris
authent
inhous
compound
well
isoliquiritigenin
kaempferol
quercetin
quercetinbgalactosid
perform
assess
potenti
novel
cov
cystein
proteas
inhibitor
vitro
present
result
indic
compound
may
serv
lead
compound
develop
cov
proteas
inhibitor
use
elucid
structurefunct
relationship
vari
polyphenol
root
b
papyrifera
collect
gonyang
sacheon
south
korea
juli
identifi
prof
myong
gi
chung
herbarium
gyeongsang
nation
univers
gnuc
voucher
specimen
khpark
deposit
gnuc
nuclear
magnet
reson
nmr
spectra
analyz
use
bruker
spectromet
bruker
karlsruh
germani
chemic
shift
repres
part
per
million
ppm
thin
layer
chromatographi
tlc
perform
precoat
silicagel
plate
plate
cm
merck
darmstadt
germani
spot
visual
uv
illumin
nm
spray
h
ethanol
follow
heat
solvent
extract
isol
purchas
sk
chemic
co
seoul
south
korea
redistil
use
deioniz
water
prepar
ultrapur
water
process
milliq
purif
system
mx
millipor
billerica
solvent
nmr
experi
cdcl
cd
co
cd
od
purchas
cambridg
isotop
laboratori
inc
andov
dri
root
b
papyrifera
g
extract
ethanol
l
three
time
room
temperatur
evapor
use
rotari
evapor
temperatur
c
obtain
total
extract
g
portion
residu
g
fraction
reversedphas
rp
silica
gel
column
cm
ymc
od
aqhg
lm
g
use
puriflash
mediumpressur
liquid
chromatographi
mplc
system
interchim
franc
linear
gradient
ch
ohh
mlmin
flow
rate
gener
nine
fraction
bp
fr
bp
fr
exhibit
potent
anticoronavir
activ
among
fraction
select
isol
activ
compound
bp
fr
mg
isol
prepar
highperform
liquid
chromatographi
prephplc
use
plc
ethanol
extract
subfract
analyz
ultraperform
liquid
chromatographyphotodiod
arrayquadrupoletim
flightmass
spectrometri
uplcpdaqtofm
chromatograph
separ
perform
mm
lm
water
acquiti
beh
chromatographi
column
c
mobil
phase
b
water
formic
acid
acetonitril
formic
acid
respect
solvent
gradient
program
follow
min
b
min
b
wash
min
b
recycl
time
min
flow
rate
mlmin
mass
spectromet
oper
posit
ion
mode
n
use
desolv
ga
desolv
temperatur
set
c
flow
rate
lh
sourc
temperatur
c
capillari
cone
voltag
set
v
respect
water
qtof
premier
tm
spectromet
oper
v
mode
mass
resolv
power
data
collect
test
sampl
da
scan
time
interscan
delay
analysi
time
leucineenkephalin
use
refer
compound
mz
neg
mode
infus
flow
rate
llmin
sarscov
pro
pl
pro
prepar
accord
previous
describ
method
express
histag
sarscov
pro
pl
pro
recombin
plasmid
transform
escherichia
coli
codonplusril
compet
cell
stratagen
la
jolla
ca
purifi
proteas
store
c
use
assay
describ
sequenc
merscov
pl
pro
genbank
access
number
polyprotein
residu
merscov
pro
genbank
access
number
polyprotein
residu
synthes
bioneer
co
daejeon
south
korea
digest
nheixhoi
insert
vector
novagen
contain
histag
cterminu
figur
construct
plasmid
transform
e
coli
hit
compet
cell
real
biotech
co
taipei
taiwan
streak
lb
agar
plate
contain
lgml
kanamycin
c
largescal
protein
express
cultur
grown
l
lb
medium
c
absorb
nm
induc
overnight
incub
mm
isopropyl
bdthiogalactopyranosid
iptg
c
centrifug
g
c
min
cell
pellet
suspend
buffer
mm
sodium
phosphat
mm
nacl
mm
imidazol
triton
ph
lyse
sonic
crude
extract
centrifug
rpm
min
remov
insolubl
pellet
supernat
load
onto
nisepharos
column
equilibr
buffer
column
wash
buffer
protein
sampl
elut
mm
imidazol
elut
buffer
chang
mm
trishcl
buffer
ph
protein
concentr
use
amicon
ultra
filter
molecular
weight
cutoff
merck
millipor
ltd
carrigtwohil
ireland
enzym
concentr
determin
absorb
nm
puriti
molecular
weight
merscov
pro
merscov
pl
pro
verifi
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
purifi
proteas
approxim
kda
pro
kda
pl
pro
kinet
paramet
enzymat
activ
analyz
fluoresc
substrat
whose
concentr
rang
lm
k
valu
lm
merscov
pro
lm
merscov
pl
pro
figur
purifi
protein
store
c
use
assay
describ
enzym
activ
merscov
pro
measur
cleavag
synthet
peptid
dabcyltsgvlqsglvkedan
site
merscov
pro
polyprotein
use
fluoresc
reson
energi
transfer
fret
method
peptid
synthes
anygen
co
gwangju
south
korea
approxim
puriti
determin
hplc
rp
column
cleavag
activ
enzym
assay
incub
nm
merscov
pro
lm
peptid
substrat
min
c
total
volum
mm
sodium
phosphat
buffer
contain
mm
nacl
ph
enhanc
fluoresc
due
proteasecatalyz
substrat
cleavag
measur
excit
wavelength
nm
emiss
wavelength
nm
use
fluoresc
plate
reader
bioteck
instrument
inc
winooski
vt
merscov
pro
inhibit
assay
isol
compound
nm
merscov
pro
lm
individu
compound
mix
substrat
lm
c
fluoresc
intens
monitor
enzym
activ
fit
experiment
data
logist
curv
equat
determin
use
timedr
protocol
initi
veloc
record
rang
concentr
data
analyz
nonlinear
regress
use
sigma
plot
systat
softwar
inc
san
jose
ca
enzym
activ
merscov
pl
pro
measur
modifi
sarscov
pl
pro
assay
previous
describ
fluorogen
peptid
argleuargglyglyamc
enzo
life
scienc
farmingdal
ny
nm
purifi
merscov
pl
pro
mm
sodium
acet
buffer
ph
use
substrat
enzym
respect
inhibit
studi
nm
merscov
pl
pro
lm
individu
compound
mix
substrat
lm
c
fluoresc
intens
monitor
excit
emiss
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
sunnyval
ca
inhibitori
effect
compound
sarscov
pro
activ
measur
use
fret
method
assay
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
anygen
co
republ
korea
use
substrat
enzym
activ
determin
measur
increas
fluoresc
intens
continu
monitor
reaction
nm
excit
nm
use
fluoresc
plate
reader
bioteck
instrument
inc
min
reaction
mixtur
contain
lgml
sarscov
pro
final
concentr
lg
activ
sarscov
pl
pro
measur
use
method
previous
describ
group
inhibit
assay
optim
plate
establish
suitabl
assay
condit
incub
time
fluorogen
peptid
argleuargglyglyamc
enzo
life
scienc
farmingdal
ny
nm
purifi
sarscov
pl
pro
mm
trishcl
buffer
ph
use
substrat
enzym
respect
inhibit
studi
nm
sarscov
pl
pro
lm
individu
compound
mix
substrat
lm
c
fluoresc
intens
monitor
excit
emiss
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
studi
kinet
sarscov
pl
pro
inhibit
compound
variou
concentr
compound
mix
sarscov
pl
pro
assay
buffer
contain
predetermin
substrat
inhibit
constant
k
calcul
nonlinear
regress
analysi
fit
differ
model
enzym
inhibit
kinet
data
use
sigmaplot
enzym
kinet
modul
systat
softwar
inc
san
jose
ca
inhibit
mechan
compound
determin
compar
statist
result
includ
akaik
inform
criterion
correct
aicc
differ
inhibit
model
select
one
best
fit
fluorogen
substrat
ubamc
enzo
life
scienc
ad
concentr
nm
mm
trishcl
buffer
ph
use
deubiquitin
assay
previous
describ
enzymat
activ
c
determin
continu
monitor
fluoresc
emiss
excit
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
co
sunnyval
ca
releas
amc
measur
manner
describ
previous
sarscov
pl
pro
inhibit
assay
interferonstimul
gene
amc
boston
biochem
cambridg
perform
plate
c
mm
trishcl
buffer
ph
contain
nm
sarscov
pl
pro
variou
concentr
compound
rang
lm
surfac
plasmon
reson
spr
measur
perform
reichert
spr
instrument
depew
ny
kindli
provid
loan
woojung
bsc
inc
suwonsi
korea
enzym
dialyz
phosphatebuff
salin
pb
ph
prior
immobil
surfac
dextranco
chip
cmdh
carboxymethyldextran
hydrogel
chip
activ
inject
edcsulfonh
mixtur
mm
concentr
protein
dilut
lgml
use
mm
sodium
acet
buffer
ph
inject
min
activ
site
quench
ethanolamin
buffer
ph
wash
pb
ph
bind
surfac
stabil
blank
inject
pb
use
run
sampl
dilut
buffer
experi
test
inhibitor
first
prepar
mm
stock
solut
dimethyl
sulfoxid
dmso
dilut
pb
immedi
prior
experi
bind
reaction
analyz
autom
run
twofold
dilut
seri
two
zero
concentr
inject
regener
step
perform
use
mm
naoh
data
analyz
softwar
refer
blank
bind
dissoci
curv
fit
global
twostat
bind
kinet
model
high
potenc
chloroform
extract
ic
lgml
aglucosidas
indic
presenc
compound
may
therapeut
infecti
diseas
therefor
major
compound
bp
fr
expect
exhibit
enzym
inhibitori
activ
uplcpdaqtofm
analys
carri
use
column
linear
gradient
acetonitril
water
peak
character
use
ms
mz
valu
molecular
ion
mh
compound
respect
supplementari
materi
isol
ten
activ
compound
use
prephplc
octadecylfunction
silica
gel
isol
compound
character
comparison
spectroscop
data
includ
mass
spectral
data
molecular
ion
uvvi
absorpt
maxima
optic
rotat
publish
previous
compound
identifi
broussochalcon
b
broussochalcon
papyriflavonol
kazinol
kazinol
b
broussoflavan
kazinol
f
kazinol
j
figur
first
express
cov
cystein
proteas
pro
sarspl
pro
pro
merspl
pro
e
coli
purifi
protein
homogen
determin
activ
fluorometr
cleavag
assay
ic
valu
isol
compound
measur
abil
inhibit
catalyt
activ
proteas
calcul
fit
data
logic
deriv
equat
also
examin
aglucosidas
inhibitori
capac
isol
compound
compound
show
dosedepend
inhibitori
effect
aglucosidas
cystein
proteas
result
cov
cystein
proteas
inhibit
assay
summar
tabl
test
polyphenol
show
dosedepend
inhibitori
effect
sarscov
pl
pro
figur
shown
tabl
compound
potent
sarscov
pl
pro
compar
cystein
proteas
ic
valu
compound
transcleavag
activ
sarscov
pro
rang
lm
among
isol
polyphenol
group
prenyl
substitut
flavan
exhibit
potent
inhibitori
effect
sarscov
pro
effect
quercetin
ic
lm
gener
structuralact
relationship
deduc
data
exampl
molecul
group
satur
chromenon
dihydroxi
group
ring
c
show
higher
inhibitori
activ
close
prenyl
group
ic
lm
chalcon
ic
lm
biphenyl
propanoid
ic
lm
moder
inhibit
sarscov
pro
activ
furthermor
activ
compound
significantli
affect
subtl
chang
molecular
structur
prenyl
methyl
vide
infra
prenyl
flavon
deriv
exhibit
highest
inhibitori
effect
sarscov
pl
pro
ic
lm
posit
two
prenyl
group
substanti
effect
sarscov
pl
pro
inhibit
correspond
compound
sarscov
pl
pro
inhibitori
potenc
prenyl
flavon
consider
higher
flavon
deriv
includ
keampferol
ic
lm
quercetin
ic
lm
quercetinbgalactosid
ic
lm
probabl
presenc
prenyl
group
within
resorcinol
group
allow
format
strong
hydrophob
interact
enzym
addit
increas
number
hydroxyl
group
flavon
backbon
result
higher
inhibitori
activ
note
lower
ic
valu
quercetin
lm
compar
kaempferol
ic
lm
among
chalcon
deriv
close
prenyl
ring
chromenon
character
group
ring
b
diminish
proteas
inhibitori
activ
observ
ic
lm
ic
lm
isoliquiritigenin
ic
lm
ic
lm
contrast
number
prenyl
group
degre
satur
effect
prenyl
flavan
shown
tabl
exhibit
moder
inhibitori
activ
ic
valu
rang
lm
addit
compound
contain
methoxi
group
also
present
correspond
biphenyl
propanoid
twofold
effect
ic
lm
unmethyl
investig
proteas
inhibit
mechan
examin
effect
compound
correspond
compound
kinet
substrat
proteolysi
kinet
studi
show
compound
exhibit
noncompetit
inhibit
base
lineweaverburk
plot
vs
xaxi
intercept
figur
inhibit
sarscov
pl
pro
activ
decreas
increas
concentr
substrat
inhibitor
studi
exhibit
mode
inhibit
k
valu
compound
calcul
dixon
plot
tabl
surfac
plasmon
reson
use
techniqu
monitor
molecular
reaction
realtim
use
determin
bind
specif
well
rate
associ
dissoci
ligand
target
protein
studi
sarscov
pl
pro
immobil
sensor
chip
potent
pl
pro
inhibitor
compound
pass
sensor
surfac
shown
figur
interact
compound
sarscov
pl
pro
due
specif
bind
event
spr
sensorgram
record
differ
concentr
compound
use
determin
kineticbind
paramet
associ
rate
constant
k
lm
dissoci
rate
constant
k
sarscov
pl
pro
compound
increas
spr
sensorgram
signific
dosedepend
manner
k
k
k
interact
compound
sarscov
pl
pro
indic
classic
interact
k
lm
k
k
lm
although
inhibit
assay
reveal
compound
second
potent
inhibitor
sarscov
pl
pro
k
higher
compound
recent
year
pl
pro
focu
numer
studi
develop
chemotherapeut
drug
covinduc
diseas
part
protein
cleav
boundari
recogn
lxgg
consensu
motif
addit
pl
pro
exhibit
deubiquitin
dub
activ
antagon
induct
interferon
ifn
interferonstimul
gene
one
upregul
gene
upon
type
ifn
stimul
involv
tag
newli
synthes
protein
antivir
respons
ubiquitin
may
import
implic
viral
replic
pathogenesi
sarscov
pl
pro
cleav
ubiquitin
cellular
conjug
similarli
merscov
pl
pro
also
shown
possess
dub
activ
thu
effect
anticov
drug
one
inhibit
viral
proteas
activ
well
dub
activ
sinc
inhibit
sarscov
pl
pro
postul
efficaci
would
higher
dub
activ
compound
strongli
inhibit
cleavag
ubiquitin
ic
valu
lm
respect
complet
substitut
prenyl
group
vs
quercetin
ic
valu
lm
respect
introduct
hydroxyl
group
strongli
affect
activ
quercetin
vs
kaempferol
ic
valu
lm
respect
test
compound
display
moder
inhibit
vitro
cleavag
ubiquitin
ic
lm
ic
lm
tabl
date
function
dub
activ
pl
pro
vivo
unknown
ident
vivo
cellular
substrat
thu
investig
necessari
determin
specif
inhibit
measur
cleavag
ubiquitinlik
protein
could
reveal
whether
deisgyl
pl
pro
mechan
sarscov
inactiv
ifnabinduc
innat
immun
respons
determin
whether
isol
compound
describ
earlier
effect
inhibitor
merscov
cystein
proteas
inhibitori
potenti
assess
use
recombin
pl
proteas
express
laboratori
shown
tabl
none
compound
potent
select
merscov
cystein
proteas
compound
effect
inhibit
merscov
pro
activ
ic
lm
similar
effect
sarscov
pro
also
compar
mode
action
subtl
structur
chang
hand
isol
polyphenol
show
signific
inhibitori
activ
merscov
pl
pro
ic
valu
rang
lm
potent
merscov
pl
pro
inhibitor
biphenyl
propanoid
compound
ic
lm
sarscov
recent
emerg
merscov
abl
cross
speci
barrier
spread
rapidli
among
human
studi
assess
inhibitori
activ
polyphenol
deriv
b
papyrifera
cov
cystein
proteas
isol
polyphenol
markedli
inhibit
pl
cov
proteas
ic
valu
compound
though
higher
peptidederiv
inhibitor
still
low
micromolar
rang
particular
isol
compound
exert
signific
sarscov
pl
pro
inhibitori
activ
noncompetit
inhibit
prenyl
quercetin
deriv
show
potent
pl
pro
inhibitori
activ
ic
lm
addit
perform
detail
proteininhibitor
sprbind
analys
compound
sarscov
pl
pro
cellular
deubiquitin
deisgyl
activ
compound
also
discuss
base
enzymat
data
show
signific
activ
compound
cov
proteas
aim
design
effect
cov
inhibitor
futur
studi
